IL1B and rheumatoid arthritis: Conversely, Fechtner et al. (2019) reported that pretreatment of RA synovial fibroblasts (RASFs) with JWH133 did not attenuate IL-1β-mediated IL-6 and IL-8 production and upregulated the expression of COX-2.